These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3459642)

  • 21. Evaluation of the resistance mechanisms of gentamicin-resistant Gram-negative bacilli and their susceptibility to tobramycin, netilmicin and amikacin.
    Maes P
    J Antimicrob Chemother; 1985 Mar; 15(3):283-9. PubMed ID: 3997704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
    Nilsson L; Sörén L
    J Antimicrob Chemother; 1986 Sep; 18(3):317-24. PubMed ID: 3771425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of the phenotypes of resistance of enterobacteriaceae to aminoglycosides with ATB Plus Expert System].
    Peyret M; Albertini MT; Olleon M; Davenas C; Blanc V
    Pathol Biol (Paris); 1993 Apr; 41(4):329-36. PubMed ID: 8233631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
    Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
    Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefotaxime aminoglycoside interactions.
    Pierce MA; Elliott AM; Cobbs CG
    Chemotherapy; 1985; 31(5):336-45. PubMed ID: 4053733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin.
    Machka K; Dietz R
    Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
    Kedzia WB; Mirska I
    J Chemother; 1989 Jul; 1(4 Suppl):367-8. PubMed ID: 16312443
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro activity of ceftriaxone alone and in combination with gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.
    Watanakunakorn C
    Antimicrob Agents Chemother; 1983 Aug; 24(2):305-6. PubMed ID: 6314890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro comparative study of piperacillin-aminoglycosides combinations against Enterococci and Enterobacteriaceae].
    Chanal M; Sirot D; Cluzel M; Sirot J; Rubio D; Joly B; Cluzel R
    Presse Med; 1986 Dec; 15(46):2313-6. PubMed ID: 2949274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
    Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacteriostatic and bactericidal effect of cefotaxime combinations on Staphylococcus aureus assessed by FIC and FBC-index determination].
    Reynaud A; Drugeon HB; Courtieu AL
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):545-9. PubMed ID: 3911153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility of Malassezia pachydermatis to aminoglycosides.
    Silva FA; Conde-Felipe M; Rosario I; Ferrer O; Real F; Déniz S; Acosta F; Padilla D; Acosta-Hernández B
    Mycoses; 2017 Dec; 60(12):796-799. PubMed ID: 28925032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.